as on March 10, 2026 at 6:11 am IST
Day's Low
Day's High
1.84%
Downside
0.52%
Upside
52 Week's Low
52 Week's High
68.26%
Downside
10.26%
Upside
Check ASTRAZENECA PLC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$301.1B
EPS (TTM)
6.8687
Dividend Yield
1.69%
Quarterly Earnings Growth YOY
0.54%
PE Ratio (TTM)
29.65
Industry PE ratio
19.52111111111111
PEG Ratio
1.584
EBITDA
19.3B
Revenue (TTM)
58.7B
Profit Margin
17.41%
Return On Equity TTM
22.84%
Track how ASTRAZENECA PLC P/E has moved over time to understand its valuation trends.
ASTRAZENECA PLC in the last 5 years
Lowest (-90.30x)
March 31, 2022
Industry (19.52x)
March 9, 2026
Today (29.65x)
March 9, 2026
Highest (48.58x)
September 30, 2022
Today’s Price to Earnings Ratio: 29.65x
Compare market cap, revenue, PE, and other key metrics of ASTRAZENECA PLC with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $301.1B | 294.2% | 29.65 | 17.41% | |
| BUY | $886.4B | 380.49% | 43.1 | 31.67% | |
| BUY | $579.3B | 52.44% | 21.8 | 28.46% | |
| BUY | $406.9B | 115.48% | 97.09 | 6.91% | |
| BUY | $286.3B | 56.18% | 15.91 | 28.08% |
The ASTRAZENECA PLC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
ASTRAZENECA PLC investment value today
Current value as on today
₹2,54,663
Returns
₹1,54,663
(+154.66%)
Returns from ASTRAZENECA PLC Stock
₹1,48,929 (+148.93%)
Dollar Returns*
₹5,734 (+5.73%)
Based on 38 analysts
81.58%
Buy
15.79%
Hold
2.63%
Sell
Based on 38 analysts, 81.58% of analysts recommend a 'BUY' rating for ASTRAZENECA PLC. Average target price of $193.43
Get share price movements and forecasts by analysts on ASTRAZENECA PLC.
What analysts predicted
0.26%UPSIDE
Target Price
$193.43
Current Price
$192.92
Analyzed by
38 Analysts
Target
$193.43
ASTRAZENECA PLC target price $193.43, a slight upside of 0.26% compared to current price of $192.92. According to 38 analysts rating.
Investment in ASTRAZENECA PLC Shares on INDmoney has dropped by -25.66% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for ASTRAZENECA PLC Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:24% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 09 March
Mon, 07:54 PM
-AstraZeneca's Koselugo approved in Canada for NF1 treatment; shares drop 1.9% to $190.61.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
AstraZeneca PLC has shown consistent revenue growth over the last four quarters, increasing from $13.58 billion to $15.50 billion. This represents an average increase of 4.3% in revenue each quarter, indicating a positive trend in the company's financial performance.
Best in 1 Year
![]()
In the last 1 year, AZN has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 months, AZN stock has moved up by 116.2%
Best in 3 Years
![]()
In the last 3 years, AZN has outperformed top 5 stocks with highest market-cap in its industry
Profit Down
![]()
AstraZeneca PLC has experienced a decline in net profit over the last two quarters, with profits decreasing from $2.53 billion to $2.32 billion. This represents an average decrease of 8.2% per quarter.
| Organisation | ASTRAZENECA PLC |
| Headquarters | 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA |
| Industry | Health Technology |
| CEO | Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Susan Mary Galbraith M.D., Ph.D. | Executive Vice President of Oncology R&D |
Ms. Iskra Reic | Executive Vice President of International |
Mr. Joris Silon | Head of Investor Relations |
Dr. Ruud Dobber Ph.D. | Executive Vice-President of BioPharmaceuticals Business Unit |
Ms. Pam P. Cheng | EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board |
Mr. Jeffrey Pott J.D. | CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board |
Mr. David Fredrickson | Executive Vice-President of Oncology Haematology Business Unit |
Ms. Ruth March | Senior VP of Precision Medicine - R&D Oncology |
Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. | CEO & Executive Director |
Dr. Aradhana Sarin M.D. | CFO & Executive Director |
ASTRAZENECA PLC share price today is $192.92 as on . ASTRAZENECA PLC share today touched a day high of $193.93 and a low of $189.37.
ASTRAZENECA PLC share touched a 52 week high of $212.71 on and a 52 week low of $61.24 on . ASTRAZENECA PLC stock price today i.e. is trending at $192.92,which is 9.30% down from its 52 week high and 215.02% up from its 52 week low.
ASTRAZENECA PLC market capitalisation is $0.30T as on .
Indian investors can start investing in ASTRAZENECA PLC (AZN) shares with as little as ₹92.306 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.06 in ASTRAZENECA PLC stock (as per the Rupee-Dollar exchange rate as on ).
Based on ASTRAZENECA PLC share’s latest price of $192.92 as on March 10, 2026 at 12:41 am IST, you will get 0.0518 shares of ASTRAZENECA PLC. Learn more about
fractional shares .
ASTRAZENECA PLC stock has given 294.2% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?